Corneal side effects induced by EGFR-inhibitor antibody–drug conjugate ABT-414 in patients with recurrent glioblastoma: a prospective clinical and confocal microscopy study

BACKGROUND: The aim of this study was to prospectively analyse, for the first time worldwide by in vivo clinical confocal microscopy (CCM), corneal side effects secondary to the use of epidermal growth factor receptor (EGFR) inhibitor depatuxizumab mafodotin (ABT-414) in a cohort of patients affecte...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Ther Adv Med Oncol
Hauptverfasser: Parrozzani, Raffaele, Lombardi, Giuseppe, Midena, Edoardo, Leonardi, Francesca, Londei, Davide, Padovan, Marta, Caccese, Mario, Marchione, Giulia, Bini, Silvia, Zagonel, Vittorina, Frizziero, Luisa
Format: Artigo
Sprache:Inglês
Veröffentlicht: SAGE Publications 2020
Schlagworte:
Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7278095/
https://ncbi.nlm.nih.gov/pubmed/32550861
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920907543
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge